National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Brimica® Genuair® is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.

Rapid Review

Commenced Completed Outcome
05/01/2015 09/02/2015 Full Pharmacoeconomic Evaluation Recommended at submitted price.

The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.